Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: A phase II randomized clinical trial

E. David Crawford, Kathryn Hirst, John W. Kusek, Robert F. Donnell, Steven A. Kaplan, Kevin T. McVary, Lance A. Mynderse, Claus Roehrborn, Christopher P. Smith, Reginald Bruskewitz